29
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Changed Nocturnal Sleep Structure and Higher Anxiety, Depression, and Fatigue in Patients with Narcolepsy Type 1

, , , , , ORCID Icon, & show all
Pages 725-735 | Received 30 Nov 2023, Accepted 11 May 2024, Published online: 07 Jun 2024

References

  • Tiseo C, Vacca A, Felbush A, et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21(1):126. doi:10.1186/s10194-020-01192-5
  • Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci. 2019;20(2):83–93. doi:10.1038/s41583-018-0097-x
  • Disorders CSoS. Chinese guidelines for diagnosis and treatment of narcolepsy (2022). Chin J Neurol. 2022;55(5):406–420.
  • Bassetti CLA, Adamantidis A, Burdakov D, et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15(9):519–539. doi:10.1038/s41582-019-0226-9
  • Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100. doi:10.1038/nrdp.2016.100
  • Ouyang H, Han F, Zhou ZC, Zhang J. Differences in clinical and genetic characteristics between early- and late-onset narcolepsy in a Han Chinese cohort. Neural Regen Res. 2020;15(10):1887–1893. doi:10.4103/1673-5374.280322
  • Wu M, Li X, Li SX, et al. Early- and late-onset narcolepsy: possibly two distinct clinical phenotypes. Sleep Breath. 2023;27(6):2443–2452. doi:10.1007/s11325-023-02820-5
  • Nevsimalova S, Pisko J, Buskova J, et al. Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol. 2013;260(3):767–775. doi:10.1007/s00415-012-6702-4
  • Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469–474. doi:10.1016/S0896-6273(00)00058-1
  • Iranzo A. Sleep and neurological autoimmune diseases. Neuropsychopharmacology. 2020;45(1):129–140.
  • Latorre D, Kallweit U, Armentani E, et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature. 2018;562(7725):63–68. doi:10.1038/s41586-018-0540-1
  • Ruoff CM, Reaven NL, Funk SE, et al. High rates of psychiatric comorbidity in narcolepsy: findings From the Burden of Narcolepsy Disease (BOND) study of 9312 patients in the United States. J Clin Psychiatry. 2017;78(2):171–176. doi:10.4088/JCP.15m10262
  • Cohen A, Mandrekar J, St Louis EK, Silber MH, Kotagal S. Comorbidities in a community sample of narcolepsy. Sleep Med. 2018;43:14–18. doi:10.1016/j.sleep.2017.11.1125
  • Lee MJ, Lee SY, Yuan SS, et al. Comorbidity of narcolepsy and depressive disorders: a nationwide population-based study in Taiwan. Sleep Med. 2017;39:95–100. doi:10.1016/j.sleep.2017.07.022
  • Inocente CO, Gustin MP, Lavault S, et al. Depressive feelings in children with narcolepsy. Sleep Med. 2014;15(3):309–314. doi:10.1016/j.sleep.2013.08.798
  • Lopez R, Barateau L, Evangelista E, Dauvilliers Y. Depression and hypersomnia: a complex association. Sleep Med Clin. 2017;12(3):395–405. doi:10.1016/j.jsmc.2017.03.016
  • Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. doi:10.1378/chest.14-0970
  • Vignatelli L, Plazzi G, Peschechera F, Delaj L, D’Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med. 2011;12(1):19–23. doi:10.1016/j.sleep.2010.07.008
  • World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545. doi:10.1093/sleep/14.6.540
  • Peng LL, Li JR, Sun JJ, et al. Epworth 嗜睡量表简体中文版信度和效度评价 [Reliability and validity of the simplified Chinese version of Epworth sleepiness scale]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;46(1):44–49. Chinese.
  • Alqurashi YD, Dawidziuk A, Alqarni A, et al. A visual analog scale for the assessment of mild sleepiness in patients with obstructive sleep apnea and healthy participants. Ann Thorac Med. 2021;16(2):141–147. doi:10.4103/atm.ATM_437_20
  • Tong X, An DM, McGonigal A, Park SP, Zhou D. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 2016;120:31–36. doi:10.1016/j.eplepsyres.2015.11.019
  • Del Bianco C, Ulivi M, Liguori C, et al. Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2. Sleep Biol Rhythms. 2023;21(1):39–50. doi:10.1007/s41105-022-00414-4
  • Xi Y, Elkana O, Jiao WE, Li D, Tao ZZ. Associations between social support and anxiety during the COVID-19 lockdown in young and middle-aged Israelis: a cross-sectional study. World J Psychiatr. 2022;12(9):1194–1203. doi:10.5498/wjp.v12.i9.1194
  • Sun XY, Li YX, Yu CQ, Li LM. 中文版抑郁量表信效度研究的系统综述 [Reliability and validity of depression scales of Chinese version: a systematic review]. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(1):110–116. Chinese.
  • Wasling HB, Bornstein A, Wasling P. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study. Sleep Med. 2020;76:104–112. doi:10.1016/j.sleep.2020.10.014
  • Zhao LP, Huang G, Duan YX, Wang Y, Chen GM, Zhang WW. 结直肠癌抑郁患者的静息态脑功能低频振幅研究 [Amplitude of low-frequency fluctuations of resting-state functional MRI in colorectal cancer patients with depression]. Zhonghua Zhong Liu Za Zhi. 2019;41(11):844–848. Chinese.
  • Wang MY, Liu IC, Chiu CH, Tsai PS. Cultural adaptation and validation of the Chinese version of the Fatigue Severity Scale in patients with major depressive disorder and nondepressive people. Qual Life Res. 2016;25(1):89–99.
  • Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31(11):1601–1607. doi:10.1093/sleep/31.11.1601
  • Berry RBQS, Abreu AR. for the American Academy of Sleep Medicine. Am Acad Sleep Med. 2020;2020:1419–1425.
  • Berry RB, Brooks R, Gamaldo C, et al. AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med. 2017;13(5):665–666. doi:10.5664/jcsm.6576
  • Siegenthaler P, Valko PO, Renzel R, et al. How reliable is a simplified MSLT nap termination protocol? Sleep Med. 2023;109:285–292. doi:10.1016/j.sleep.2023.07.016
  • Inocente CO, Lavault S, Lecendreux M, et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther. 2013;19(7):521–528. doi:10.1111/cns.12105
  • Xu X, Wu HJ, Zhuang JH, et al. Sleep-wake patterns, non-rapid eye movement, and rapid eye movement sleep cycles in teenage narcolepsy. Sleep Med. 2017;33:47–56. doi:10.1016/j.sleep.2016.08.012
  • Nevsimalova S. The diagnosis and treatment of pediatric narcolepsy. Curr Neurol Neurosci. 2014;14(8):469.
  • Zhang Y, Ren R, Yang LH, et al. Polysomnographic nighttime features of narcolepsy: a systematic review and meta-analysis. Sleep Med Rev. 2021;58:101488. doi:10.1016/j.smrv.2021.101488
  • Schoch SF, Werth E, Poryazova R, Scammell TE, Baumann CR, Imbach LL. Dysregulation of sleep behavioral states in narcolepsy. Sleep. 2017;40(12). doi:10.1093/sleep/zsx170
  • Dauvilliers Y, Jennum P, Plazzi G. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy. Sleep Med. 2013;14(8):775–781. doi:10.1016/j.sleep.2012.10.006
  • Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. 2010;133(2):568–579. doi:10.1093/brain/awp320
  • Antelmi E, Pizza F, Franceschini C, Ferri R, Plazzi G. REM sleep behavior disorder in narcolepsy: a secondary form or an intrinsic feature? Sleep Med Rev. 2020;50:101254. doi:10.1016/j.smrv.2019.101254
  • Frauscher B, Ehrmann L, Mitterling T, et al. Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the Innsbruck narcolepsy cohort. J Clin Sleep Med. 2013;9(8):805–812. doi:10.5664/jcsm.2926
  • Pataka AD, Frangulyan RR, Mackay TW, Douglas NJ, Riha RL. Narcolepsy and sleep-disordered breathing. Eur J Neurol. 2012;19(5):696–702. doi:10.1111/j.1468-1331.2011.03610.x
  • Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235. doi:10.1056/NEJM199304293281704
  • Pizza F, Tartarotti S, Poryazova R, Baumann CR, Bassetti CL. Sleep-disordered breathing and periodic limb movements in narcolepsy with cataplexy: a systematic analysis of 35 consecutive patients. Eur Neurol. 2013;70(1–2):22–26. doi:10.1159/000348719
  • Dauvilliers Y, Pennestri MH, Petit D, Dang-Vu T, Lavigne G, Montplaisir J. Periodic leg movements during sleep and wakefulness in narcolepsy. J Sleep Res. 2007;16(3):333–339. doi:10.1111/j.1365-2869.2007.00601.x
  • Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS. Neurobiological and immunogenetic aspects of narcolepsy: implications for pharmacotherapy. Sleep Med Rev. 2019;43:23–36. doi:10.1016/j.smrv.2018.09.006
  • Iranzo A. Parasomnias and sleep-related movement disorders in older adults. Sleep Med Clin. 2022;17(2):295–305. doi:10.1016/j.jsmc.2022.02.005
  • Staton CD, Yaeger JDW, Khalid D, et al. Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression. Neuropharmacology. 2018;143:79–94. doi:10.1016/j.neuropharm.2018.09.016
  • Del Sette P, Veneruso M, Cordani R, et al. Narcolepsy and emotions: is there a place for a theory of mind approach? Sleep Med. 2023;102:84–89. doi:10.1016/j.sleep.2022.12.013
  • Chellappa SL, Aeschbach D. Sleep and anxiety: from mechanisms to interventions. Sleep Med Rev. 2022;61:101583. doi:10.1016/j.smrv.2021.101583
  • Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): the ultimate translational neuropeptides. J Intern Med. 2022;291(5):533–556. doi:10.1111/joim.13406
  • Shan L, Linssen S, Harteman Z, et al. Activated wake systems in narcolepsy type 1. Ann Neurol. 2023;94(4):762–771. doi:10.1002/ana.26736
  • Shan L, Balesar R, Swaab DF, Lammers GJ, Fronczek R. Reduced numbers of corticotropin-releasing hormone neurons in narcolepsy type 1. Ann Neurol. 2022;91(2):282–288. doi:10.1002/ana.26300
  • Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res. 1999;33(3):181–214. doi:10.1016/S0022-3956(98)90056-5
  • Rana T, Behl T, Sehgal A, et al. Exploring the role of neuropeptides in depression and anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 2022;114:110478. doi:10.1016/j.pnpbp.2021.110478
  • Held K, Kunzel H, Ising M, et al. Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. J Psychiatr Res. 2004;38(2):129–136. doi:10.1016/S0022-3956(03)00076-1
  • Thorpy MJ. Recently approved and upcoming treatments for narcolepsy. CNS Drugs. 2020;34(1):9–27. doi:10.1007/s40263-019-00689-1
  • Chen CR, Zhong YH, Jiang S, et al. Dysfunctions of the paraventricular hypothalamic nucleus induce hypersomnia in mice. Elife. 2021;10. doi:10.7554/eLife.69909
  • Kok SW, Roelfsema F, Overeem S, et al. Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker. J Clin Endocrinol Metab. 2002;87(11):5085–5091. doi:10.1210/jc.2002-020638
  • Wang Z, Zhong YH, Jiang S, Qu WM, Huang ZL, Chen CR. Case report: dysfunction of the paraventricular hypothalamic nucleus area induces hypersomnia in patients. Front Neurosci. 2022;16:830474. doi:10.3389/fnins.2022.830474
  • Droogleever Fortuyn HA, Fronczek R, Smitshoek M, et al. Severe fatigue in narcolepsy with cataplexy. J Sleep Res. 2012;21(2):163–169. doi:10.1111/j.1365-2869.2011.00943.x
  • Cremaschi RC, Hirotsu C, Tufik S, Coelho FM. High fatigue frequency in narcolepsy type 1 and type 2 in a Brazilian sleep center. Sleep Med. 2018;52:234. doi:10.1016/j.sleep.2018.08.013
  • Johansson K, Wasling P, Axelsson M. Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy. Acta Neurol Scand. 2021;144(5):566–575. doi:10.1111/ane.13497
  • Malhotra A, Shapiro C, Pepin JL, et al. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea. Sleep. 2020;43(2). doi:10.1093/sleep/zsz220
  • Dauvilliers Y, Arnulf I, Szakacs Z, et al. Long-term use of pitolisant to treat patients with narcolepsy: harmony III Study. Sleep. 2019;42(11). doi:10.1093/sleep/zsz174